Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D3 works as anti-inflammatory

Diabetes Research and Clinical Practice

Volumn 77, Issue 1, 2007, Pages 47-57

  Giulietti, Annapaula ^a   van Etten, Evelyne ^a   Overbergh, Lut ^a   Stoffels, Katinka ^a   Bouillon, Roger ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Atherosclerosis; Cytokines; Inflammation; Monocytes; Type 2 diabetes; Vitamin D

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; B7 ANTIGEN; CALCITRIOL; CYCLOOXYGENASE 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC ANGIOPATHY; FEMALE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD80; CALCITRIOL; CYCLOOXYGENASE 2; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FEMALE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKINS; MALE; MIDDLE AGED; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247158555     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.10.007     Document Type: Article

References (59)

1. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004) 813-823
2. Duncan B.B., Schmidt M.I., Pankow J.S., et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52 (2003) 1799-1805
3. Schmidt M.I., Duncan B.B., Sharrett A.R., et al. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353 (1999) 1649-1652
4. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 (1998) 847-850
5. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
6. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E745-E751
7. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
8. Altannavch T.S., Roubalova K., Kucera P., and Andel M. Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol. Res. 53 (2004) 77-82
9. Cosentino F., Eto M., De Paolis P., et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107 (2003) 1017-1023
10. Temaru R., Urakaze M., Satou A., Yamazaki K., Nakamura N., and Kobayashi M. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin-8 in diabetic macroangiopathy. Diabetologia 40 (1997) 610-613
11. Mathieu C., Gysemans C., Giulietti A., and Bouillon R. Vitamin D and diabetes. Diabetologia 48 (2005) 1247-1257
12. Mathieu C., Van Etten E., Decallonne B., Giulietti A., Gysemans C., Bouillon R., et al. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J. Steroid Biochem. Mol. Biol. 89/90 (2004) 449-452
13. Overbergh L., Decallonne B., Valckx D., Verstuyf A., Depovere J., Laureys J., et al. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin. Exp. Immunol. 120 (2000) 139-146
14. Veldman C.M., Cantorna M.T., and DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 374 (2000) 334-338
15. Xu H., Soruri A., Gieseler R.K., and Peters J.H. 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand. J. Immunol. 38 (1993) 535-540
16. Medzhitov R., and Janeway Jr. C. Innate immunity. N. Engl. J. Med. 343 (2000) 338-344
17. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., and Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25 (2001) 386-401
18. Moriwaki Y., Yamamoto T., Shibutani Y., et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52 (2003) 605-608
19. Spranger J., Kroke A., Mohlig M., et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52 (2003) 812-817
20. Pickup J.C., Mattock M.B., Chusney G.D., and Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997) 1286-1292
21. Ceriello A., Falleti E., Bortolotti N., Motz E., Cavarape A., Russo A., et al. Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism 45 (1996) 498-501
22. Kado S., and Nagata N. Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 46 (1999) 143-148
23. Zozulinska D., Majchrzak A., Sobieska M., Wiktorowicz K., and Wierusz-Wysocka B. Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42 (1999) 117-118
24. Hu F.B., Meigs J.B., Li T.Y., Rifai N., and Manson J.E. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53 (2004) 693-700
25. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
26. Doganay S., Evereklioglu C., Er H., Turkoz Y., Sevinc A., Mehmet N., et al. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16 (2002) 163-170
27. Elner S.G., Strieter R., Bian Z.M., Kunkel S., Mokhtarzaden L., Johnson M., et al. Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy. Arch. Ophthalmol. 116 (1998) 1597-1601
28. Sennlaub F., Valamanesh F., Vazquez-Tello A., El-Asrar A.M., Checchin D., Brault S., et al. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation 108 (2003) 198-204
29. Okada S., Shikata K., Matsuda M., Ogawa D., Usui H., Kido Y., et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52 (2003) 2586-2593
30. Tashiro K., Koyanagi I., Saitoh A., Shimizu A., Shike T., Ishiguro C., et al. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J. Clin. Lab. Anal. 16 (2002) 1-4
31. Komers R., Lindsley J.N., Oyama T.T., Schutzer W.E., Reed J.F., Mader S.L., et al. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J. Clin. Invest. 107 (2001) 889-898
32. Pop-Busui R., Marinescu V., Van Huysen C., Li F., Sullivan K., Greene D.A., et al. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-l-carnitine administration. Diabetes 51 (2002) 2619-2628
33. Haddy N., Sass C., Droesch S., Zaiou M., Siest G., Ponthieux A., et al. IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 170 (2003) 277-283
34. Jude E.B., Douglas J.T., Anderson S.G., Young M.J., and Boulton A.J. Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus. Eur. J. Intern. Med. 13 (2002) 185-189
35. Linton M.F., and Fazio S. Cyclooxygenase-2 and inflammation in atherosclerosis. Curr. Opin. Pharmacol. 4 (2004) 116-123
36. Borst S.E. The role of TNF-alpha in insulin resistance. Endocrine 23 (2004) 177-182
37. Senn J.J., Klover P.J., Nowak I.A., and Mooney R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51 (2002) 3391-3399
38. Curat C.A., Miranville A., Sengenes C., et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53 (2004) 1285-1292
39. Desfaits A.C., Serri O., and Renier G. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care 21 (1998) 487-493
40. Geerlings S.E., Brouwer E.C., Van Kessel K.C., Gaastra W., Stolk R.P., and Hoepelman A.I. Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Invest. 30 (2000) 995-1001
41. Ohno Y., Aoki N., and Nishimura A. In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 77 (1993) 1072-1077
42. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75 (2004) 163-189
43. Conti G., Scarpini E., Baron P., Livraghi S., Tiriticco M., Bianchi R., et al. Macrophage infiltration and death in the nerve during the early phases of experimental diabetic neuropathy: a process concomitant with endoneurial induction of IL-1beta and p75NTR. J. Neurol. Sci. 195 (2002) 35-40
44. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
45. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
46. Osterud B., and Bjorklid E. Role of monocytes in atherogenesis. Physiol. Rev. 83 (2003) 1069-1112
47. Frostegard J., Ulfgren A.K., Nyberg P., Hedin U., Swedenborg J., Andersson U., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145 (1999) 33-43
48. Whitman S.C., Ravisankar P., Elam H., and Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am. J. Pathol. 157 (2000) 1819-1824
49. Hansson G.K., Libby P., Schonbeck U., and Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 91 (2002) 281-291
50. Buono C., Pang H., Uchida Y., Libby P., Sharpe A.H., and Lichtman A.H. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 109 (2004) 2009-2015
51. Wang N., Tabas I., Winchester R., Ravalli S., Rabbani L.E., and Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J. Biol. Chem. 271 (1996) 8837-8842
52. Fichtlscherer S., Breuer S., Heeschen C., Dimmeler S., and Zeiher A.M. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J. Am. Coll. Cardiol. 44 (2004) 44-49
53. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., et al. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
54. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., et al. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85 (1999) e17-e24
55. Shanmugam N., Gaw G., and Natarajan R. Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes. Diabetes 53 (2004) 795-802
56. Sly L.M., Lopez M., Nauseef W.M., and Reiner N.E. 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem. 276 (2001) 35482-35493
57. Chiu K.C., Chu A., Go V.L., and Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79 (2004) 820-825
58. Gedik O., and Akalin S. Effects of Vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29 (1986) 142-145
59. Pittas A.G., Dawson-Hughes B., Li T., Van Dam R.M., Willett W.C., Manson J.E., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29 (2006) 650-656